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Abstract
Background: Ethiopia is one of the African countries where Plasmodium falciparum and P. vivax co-exist. Monitoring
and evaluation of current malaria transmission status is an important component of malaria control as it is a measure
of the success of ongoing interventions and guides the planning of future control and elimination efforts.
Main text: We evaluated changes in malaria control policy in Ethiopia, and reviewed dynamics of country-wide
confirmed and clinical malaria cases by Plasmodium species and reported deaths for all ages and less than five
years from 2001 to 2016. Districts level annual parasite incidence was analysed to characterize the malaria transmission
stratification as implemented by the Ministry of Health. We found that Ethiopia has experienced major changes from
2003 to 2005 and subsequent adjustment in malaria diagnosis, treatment and vector control policy. Malaria interventions
have been intensified represented by the increased insecticide treated net (ITN) and indoor residual spraying (IRS)
coverage, improved health services and improved malaria diagnosis. However, countrywide ITN and IRS coverages were
low, with 64% ITN coverage in 2016 and IRS coverage of 92.5% in 2016 and only implemented in epidemic-prone areas
of > 2500 m elevation. Clinical malaria incidence rate dropped from an average of 43.1 cases per 1000 population
annually between 2001 and 2010 to 29.0 cases per 1000 population annually between 2011 and 2016. Malaria
deaths decreased from 2.1 deaths per 100 000 people annually between 2001 and 2010 to 1.1 deaths per 100 000
people annually between 2011 to 2016. There was shrinkage in the malaria transmission map and high transmission is
limited mainly to the western international border area. Proportion of P. falciparum malaria remained nearly unchanged
from 2000 to 2016 indicating further efforts are needed to suppress transmission.
Conclusions: Malaria morbidity and mortality have been significantly reduced in Ethiopia since 2001, however, malaria
case incidence is still high, and there were major gaps between ITN ownership and compliance in malarious areas.
Additional efforts are needed to target the high transmission area of western Ethiopia to sustain the achievements
made to date.
Keywords: Malaria control, Policy, Ethiopia, Plasmodium falciparum, Plasmodium vivax, Epidemiology, Incidence, Spatial
distribution
Multilingual abstracts
Please see Additional file 1 for translation of the abstract
into the five official working languages of the United
Nations.
Background
Malaria morbidity and mortality have been significantly
decreased in Ethiopia and worldwide in the past decade
[1]. Ethiopia’s fight against malaria started many years
ago and transmission of this infectious disease signifi-
cantly decreased since 1959 [1, 2]. However, malaria still
remains a major public health problem in Ethiopia [1].
Ethiopia has a population of nearly 100 million, and it is
estimated that ~ 68% of the population is at risk of the
disease [1, 3]. Plasmodium falciparum and P. vivax
co-exist as major parasite species in Ethiopia [1]. This
epidemiologic feature makes malaria control more com-
plicated than in most African countries where P. vivax
has low or nil endemicity.* Correspondence: zhoug@uci.edu2Program in Public Health, University of California, Irvine, CA 92697, USA
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Malaria transmission in Ethiopia occurs mainly at
altitudes < 2000 m, although endemic regions > 2000 m
have been reported [3–5]. The levels of malaria risk and
transmission intensity, however, show marked seasonal,
inter-annual and spatial variability, with the exception of
the southwestern international border low land area where
transmission is year-around [6–8]. In most regions of the
country, the major transmission season is from September
to December, following the main rainy season from June
to September [3]. There is a short transmission season
from April to May following the short rainy season in
some regions [3]. Anopheles arabiensis is the predominant
vector with An. pharoensis, An. coustani, An. funestus and
An. nili having a minor role in transmission [9]. Generally,
the diverse ecology of the country supports a wide range
of transmission intensities ranging from low-seasonal to
high-perennial transmission. For planning purposes and
targeting of intervention strategies, the Federal Ministry of
Health (FMoH) of Ethiopia has stratified the country’s
malaria transmission burden using ‘woreda’ (district)-level
transmission intensity according to annual parasite inci-
dence per 1000 population (API) and elevation [3, 10]. Ac-
cordingly, four broad strata were identified by the mixed
criteria of the FMoH and World Health Organization
(WHO) — malaria free, low, moderate, and high transmis-
sion [3, 9].
Plasmodium falciparum are endemic in many regions
of the country [3, 11–13]. Plasmodium malariae and P.
ovale infection are uncommon and account for < 1% of
confirmed malaria cases [3, 11]. Chloroquine (CQ) is
currently the recommended first-line drug for treatment
of vivax malaria [11]. In vivo monitoring of uncomplicated
vivax malaria cases indicates that the CQ is generally effi-
cacious; however, treatment failures have been reported
[14–17]. The success of malaria control efforts has largely
depended on financial support from donor funds [1].
In the past decade Ethiopia has made significant strides in
expanding coverage of key malaria interventions throughout
the country. Indoor residual spraying (IRS) using dichlorodi-
phenyltrichloroethane (DDT) was introduced in 1959 with
the global malaria eradication campaign, and since then
different chemical insecticides have been used for malaria
control [9, 18, 19]. Insecticide-treated nets (ITN) were
introduced in 1997 as an additional intervention [10].
Chloroquine was the first line treatment of all malaria
species in Ethiopia before 1998. It was replaced by sulfa-
doxine-pyrimethamine (SP) after 1998 for the treatment of
uncomplicated P. falciparum due to widespread decline in
the efficacy of CQ [20, 21]. Parasites soon developed resist-
ance to SP drugs [22, 23]. Planning for scaling-up malaria
prevention and control interventions started in 2003 with
the support from the Global Fund to Fight AIDS, Tubercu-
losis and Malaria (GFATM) [3]. In 2004, the FMoH intro-
duced artemisinin-based combination therapy (ACT) as the
first-line drug for treatment of P. falciparum malaria as
well as rapid diagnostic tests (RDT) to improve diagnosis
and long-lasting insecticidal nets (LLINs) as a method of
preventing transmission of parasite from mosquitoes to
people [3]. Major scale-up began in 2005 with country-wide
distribution of RDTs, ACTs, LLINs and implementation of
IRS [3].
The aim of this study was to provide comprehensive
evaluation of changes in national malaria control policy
and progress made in malaria control interventions and
malaria epidemiology in Ethiopia. We discuss obstacles
to malaria elimination and review national malaria data
from 2000 to 2016 and analyse these data in order to
advance understanding of how changes in policy have
impacted temporal changes in malaria transmission in
the country.
Main text
Data collection
Changes in malaria control policy were reviewed based
on different sources including FMoH publications on
malaria diagnosis, treatment and vector control guide-
lines, WHO guidelines, the President’s Malaria Initiative
(PMI), and Ethiopian malaria control operational plans
and reports [10, 11, 18, 19, 24–30]. National malaria
data from health facilities were collected through the
Health Management Information System (HMIS). Total
confirmed and clinical malaria cases, malaria cases by
species, and reported deaths for all ages and age < 5 years
between 2001 and 2016 were reviewed. Incidence rate
was expressed as malaria cases/1000 people/year and
death rate as deaths/100000 people/year. Changes in
number of health facilities, annual number of tests
(microscopic examination of blood smears and RDT)
of suspected malaria cases, reports on new insecticide
treated nets (ITN and LLIN), and IRS coverage from
2007 to 2016 were obtained from the FMoH. The in-
terventions were targeted to suit local epidemiological
situations, with case management being strengthened
in all areas. LLIN and IRS were implemented in tar-
geted areas before 2011 [3].
Annual parasite incidence (API) according to district
was analysed to characterize the district as malaria-free
(API < 1.0), low (1.1–5.0), moderate (5.1–100), or high
transmission (> 100) and to map transmission dynamics
according to district [10]. Malaria records at the district
level nation-wide were only available since 2013, and
annual district level micro-plans were used to deter-
mine API of each district in 2013 and 2016 (with the
exception of the Somali region where information from
the National Public Health Emergency Management
Plan was used). Data from a total of 845 districts were
analysed.
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Statistical analysis
API and malaria death rates were calculated based on
2007 Ethiopian government census populations and 2013
projections at district and national levels assuming
constant population growth rate over the study period.
Percent changes in malaria indicators from 2013 to
2016 were calculated according to the formula: (Value2013–
Value2016)/Value2013 × 100. Maps of API at district level
were generated using ArcGIS 10.0 (ESRI, Redlands, CA,
USA). Numbers of districts with malaria-free, low, moderate
and high API were calculated separately for 2013 and 2016.
The total population and percentage composition in differ-
ent transmission categories was calculated accordingly. The
number of districts and total populations in different trans-
mission categories were compared between 2013 and 2016
using χ2-test through free online statistical tool VassarStats:
Website for Statistical Computation (http://vassarstats.net/
index.html).
Evolving malaria control policy
The major policy changes in treatment were the replace-
ment of CQ with SP for the first line treatment of uncom-
plicated P. falciparum malaria in 1998 and subsequent
replacement with artemether-lumefantrine (AL), an ACT
drug, in 2004 (Fig. 1). Also in 2004, RDTs were imple-
mented in Ethiopia to improve diagnosis; however, the
test-treat policy, i.e., administration of antimalarial drugs
was based on test results, was implemented in 2010 (Fig. 1).
According to current national guidelines, laboratory diag-
nosis is based on microscopic examination of blood smears
at hospitals and health centres. RDTs are used at health
posts and by health extension workers based in local
communities.
CQ remains the first-line treatment of uncomplicated
vivax malaria (Fig. 1) [14–17]. Anti-relapse therapy with
primaquine for P. vivax malaria is currently recommended,
with supervised use, in malaria elimination-designated dis-
tricts [11].
LLIN were introduced into Ethiopia in 2004 as a
method of malaria prevention and control [3]. Major
scale-up began in 2005 with country-wide distribution of
LLINs free of charge (Fig. 1) [3]. LLIN distribution cam-
paigns were carried out in 2005, 2010 and 2015. Before
2011 LLIN coverage targeted all age groups in endemic
areas below 2000 m altitude. Long lasting insecticidal
nets have been provided free in all malaria endemic
areas since 2011 [27–29].
DDT and malathion were the main insecticides used for
IRS before 2007 (Fig. 1) [9]. Due to concerns of high-level
resistance to and long-term field residual effect of DDT,
pyrethriods were used for IRS from 2007 to 2010. Bendio-
carb and propoxur were used in different districts in 2011
and 2012, respectively. Pirmiphos-methyl was introduced
in PMI spraying districts in 2016 (Fig. 1) [9, 31]. Indoor
residual spraying was used in epidemic-prone areas situ-
ated at altitudes of 2000 to 2500 m. [3]. New guidelines
promote selectively IRS intervention based on API, i.e.,
IRS is used in both low (API 1~ 5) and high transmission
areas (API ≥ 100). IRS is also used in low-risk populations
located in highland epidemic fringe areas [25, 28], how-
ever, this new recommendation has not been implemented
in the field at the time this study was conducted.
Larval source reduction and laviciding has been recom-
mended as part of the vector control measures [11, 32].
Larval control is recommended for all malaria affected
areas where breeding sites are permanent, identifiable,
and few [25, 30]. Temephos (Abate®) is the recommended
larvicide [11].
Changes in clinical malaria incidence
There has been an overall reduction in reported malaria
incidence and deaths, increases LLIN and IRS coverage
and the number of health facilities from 2000 to 2016
(Fig. 2 and Table 1). Population pooled microscopically
or RDT confirmed cases increased from < 20% before
2008 to ~ 40% by 2012 and > 80% since 2013 (Fig. 2).
There were three small malaria case increases in 2004,
Fig. 1 Malaria intervention scheme in Ethiopia from 1990 to 2016
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2010, and 2012 (Fig. 2). Malaria incidence showed a
general declining trend from 2001 to 2016 with some
annual variations (Fig. 2). The average annual incidence
declined from 43.1 cases per 1000 people annually be-
tween 2001 and 2010 (before LLINs were made available
free to all malaria affected people) to 29.0 cases per 1000
people between 2011 and 2016. This declining trend was
more pronounced from 2014 to 2016 (after two rounds
of mass LLIN distribution) when the average annual in-
cidence was 22.9 cases per 1000 people (Fig. 2). Malaria
death incidence showed a similar declining trend (Fig. 2).
There were 2.1 deaths per 100 000 people annually
between 2001 and 2010 and 1.1 cases per 1 000 000
people annually between 2011 and 2016, a drop of
47%. The declining trend was more pronounced from
2014 to 2016, with an annual incidence of 0.6 cases
per 100 000 people (Fig. 2, Table 1).
Malaria diagnosis and parasite species
The number of RDT and microscopy tested suspected
malaria cases increased significantly from below one million
before 2008 to 8.6 million in 2014 and an average of 7.1
million from 2014 to 2016 (Fig. 3). Case confirmation rate
by microscopy and/or RDT increased from 79.8% in 2013
to 87.5% in 2016 (Table 1). Although there was year-to-year
variation, malaria species changed little over time. Plasmo-
dium falciparum accounted for ~ 60% of cases (range 55–
69%) and P. vivax 40% (range 31–45%) from 2001 to 2016
(Fig. 3, Table 1).
Intensification of malaria interventions and increase in
number of health facilities
FMoH has distributed 18.2 million ITN/LLINs between
2006 and 2007, 13.0 million LLINs in 2010 and 42.4
million LLINs between 2014 and 2016 (Fig. 4a). How-
ever, the nation-wide LLIN ownership (proportion of
households with at least one LLIN) has been relatively
low, 65% in 2007, 55% in 2011 and 64% in 2015. IRS
coverage increased from 20.0% in 2007 to 92.5% in 2016
in epidemic-prone areas located at altitudes ≥2500 m
(Fig. 4b). IRS was not implemented in other non-targeted
areas. Meanwhile, the number of health facilities nation-
ally has steadily increased from 3612 in 2000 to 6604 in
2005, just before the scale-up of malaria interventions.
The total number of health facilities in 2016 was 20 283
(Fig. 4c).
Fig. 2 National level annual total reported malaria cases, deaths due to malaria, and proportion of cases confirmed by microscopy or RDT from
2001 to 2016
Table 1 Changes in malaria epidemiological indicators in
Ethiopia from 2013 to 2016
Year 2013 2016 Change (%)
Total reported cases
3 316 013 1 962 996 −40.8
Confirmed 2 645 454 1 718 504 −35.0
(% confirmed) 79.8 87.5 9.7
Incidence rate (cases/1000
population)
36.6 20.2 − 44.8
P. falciparum proportion (%) 63.8 66.5 4.2
Age
< 5 years 785 895 319 795 − 59.3
(% of total) 23.7 17.1 −27.8
≥ 5 years 2 530 118 1 553 231 −38.6
Malaria admission
< 5 years 6602 6766 2.5
(% of total) 16.5 16.9 2.5
≥ 5 years 33 525 33 345 −0.5
Malaria deaths
< 5 years 43 12 −72.1
(% of total) 5.6 2.4 −58.2
≥ 5 years 721 498 −30.9
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Changes in spatial transmission patterns
Overall malaria-related hospital admissions showed no
significant change between 2013 and 2016 (Table 1). How-
ever, malaria deaths decreased significantly from 2013
to 2016. Reported malaria cases in children < 5 years
decreased by 59.3% between 2013 and 2016, from a
total of 785 895 to 319 795, respectively (Table 1). Malaria
deaths dropped by 72.1% over the same time interval, only
12 deaths were reported in 2016 (Table 1).
Spatially, areas of moderate to high transmission areas
decreased between 2013 and 2016 (Fig. 5a and b). Areas
with API > 100 (high transmission) significantly shrank
whereas areas with API ≤5 (low transmission) significantly
increased, especially in the central west region of Ethiopia
where high transmission totally disappeared (Fig. 5, Table 2).
Overall, the number of high transmission districts dropped
from 14.3 to 6.4% whereas low transmission districts
increased from 22.5 to 37.4% (χ2 = 59.97, degree of
freedom = 3, P < 0.0001) (Table 2). Proportion of the
population in high risk areas decreased from 9.5% in
2013 to 3.3% in 2016 while the proportion in low risk
areas increased from 26.7 to 42.7% (χ2 = 3.84, df = 3,
P = 0.0501) (Table 2).
The reduction in clinical malaria was not uniform across
the country (Fig. 5c). The majority of districts experienced
reductions in incidence rates from 2013 to 2016 (Fig. 5c),
with two districts having reductions of API > 500, i.e., re-
duction in API of 781 in Masha Woreda, Sheka Zone of
SNNPR region and 641 in Fagta Lakoma Woreda, Awi
Zone of Amhara Region. By contrast, there were 59 dis-
tricts with noticeable increases in clinical malaria inci-
dence (API > 5) from 2013 to 2016, and two districts with
increases in API > 100, i.e., 131 in Awash Fentale Woreda,
Zone 3 of Afar Region, and 118 in Itang Woreda, Agnuak
Zone of Gambella Region.
Progress has been made and major challenges
Progress has been made and future new interventions
Ethiopia is one of the few countries in sub-Sahara Africa
with a policy to provide the main malaria prevention
and control services free of charge, including malaria
diagnosis and treatment, mosquito nets and IRS [3, 11].
This policy has ensured accessibility of the poor to
malaria interventions and, hence, protection from malaria to
increase household economic productivity. We emphasize
that, in Ethiopia, the success of these policies largely
depended on donor funds [1, 25–30]. The overall reduc-
tion of malaria burden is evident since 2013, reflected in
the shrinkage of the malaria map between 2013 and 2016,
particularly in the central highlands of Ethiopia where no
high transmission was observed in 2016. Anti-relapse
therapy with primaquine for P. vivax malaria is not cur-
rently recommended in malaria-endemic areas [1]. How-
ever, the national malaria case management guidelines
outline the specific recommendations, including the use
of a full 14-day course of primaquine for radical cure of P.
vivax at malaria elimination-designated districts and sin-
gle dose primaquine for gametocytocidal activity against
P. falciparum in all areas of the country [26, 30]. With this
new intervention, the case burden is expected to decrease
in the near future.
There was clear decrease in malaria incidence rate and
malaria death rate in Ethiopia from 2001 to 2016; however,
malaria case number and incidence remained high—19.8
Fig. 3 National level annual total number of suspected cases tested and parasite species composition from 2001 to 2016. Pf: Plasmodium falciparum;
Pv: Plasmodium vivax
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cases per 1000 people reported in 2016 exceed the WHO
standard for “pre-elimination.” Overall LLIN ownership
and IRS coverage also continue to be low. In 2016, LLIN
ownership rate was 62% nation-wide, which is far lower
than its neighbouring country of Kenya [32, 33]. IRS cover-
age was even lower, nation-wide average coverage of 23%
from 2014 to 2016 [32]. Therefore, there is ample oppor-
tunity to increase LLIN and IRS coverage which would
be expected to decrease malaria transmission further.
There is a clear need to improve the mechanism of
LLIN distribution so that all at risk populations can be
adequately covered.
New risk factors
Although the FMoH of Ethiopia has classified areas at
altitudes > 2000 m as malaria-free zones [10], they are
not entirely malaria free at the district level. In fact, many of
these districts have moderate APIs according to this study.
These areas may have scattered seasonal micro-geographic
local transmissions due to local environmental suitability
[10, 34]. For example, construction of dams might increase
malaria transmission in the valleys of highland areas where
overall malaria transmission was very low [35]. These dams
create transmission hot spots along valleys where irrigation
is important for farming [36]. Population migration and
Fig. 4 National level: a. Annual total number of new LLIN distributed from 2006 to 2016 and household LLIN ownership (% of
households with at least one LLIN) in 2007, 2011 and 2015; b. IRS coverage (%) in targeted areas, and c. Total number of health
facilities in Ethiopia from 2000 to 2016. Pf: Plasmodium falciparum; Pv: Plasmodium vivax; LLIN: long-lasting insecticidal net; and IRS:
indoor residual spraying
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treatment-seeking behaviour may have contributed to the
high level of API observed in these highlands [37]. Further
investigation of this issue is warranted.
Confirmed cases are still high
There have been significant advances in malaria diagnosis
and prevention in Ethiopia since the beginning of scale up
in 2004 [8, 28, 38, 39]. Before 2008, over 80% of the re-
ported cases were presumptive cases lacking parasito-
logical confirmation. Presumed treatment has declined
greatly in the last few years. For example, in 2016, the an-
nual performance report showed that 6 367 309 suspected
cases were examined by microscopy or RDTs, with a total
number of 1 718 504 confirmed cases by either method.
Meanwhile, the FMoH reported the total number of clin-
ical malaria cases to be 1 962 996, and the proportion of
clinically diagnosed cases based on symptoms alone re-
duced to 12.5% in 2016. This was a result of successful im-
plementation of the malaria test-treat policy.
Challenges for further reducing malaria transmission
Malaria transmission is very heterogeneous across Ethiopia.
The malaria burden is still high in western Ethiopia near
the borders of Sudan and South Sudan. This suggests that
these high burden areas need to be prioritized to sustain
the gains made so far and achieve malaria elimination. In
central Ethiopia, particularly the central highlands, malaria
transmission has been significantly reduced, and many
of these areas have reached pre-elimination levels of
transmission. These results are similar to those of a previ-
ous study showing a reduction in malaria incidence in
central Ethiopia after ITN distribution [40–42]. Neverthe-
less, malaria epidemiology in western Ethiopia has clearly
been under-studied [10, 38, 39]. In addition, dealing with
how to prevent resurgence and re-introduction is a new
challenge for the central highlands. Finally, in the Somalia
Region of eastern Ethiopia bordering Somalia where mal-
aria reporting is less accurate due to inadequate capacity,
better surveillance systems are desperately needed in the
era of malaria elimination [10].
Conclusions
Malaria morbidity and mortality have significantly de-
clined in Ethiopia since 2000. However, transmission
remains high in the western border area near Sudan and
South Sudan. Appropriate vector control methods that
target outdoor transmission are needed, especially for
migrant workers and for people who work at night.
Additional efforts are needed to target the high transmis-
sion area of western Ethiopia to sustain achievements made
to date and hasten the endeavour of achieving malaria
elimination.
Table 2 Changes in distribution of malaria transmission intensity and affected populations at district level in Ethiopia from
2013 to 2016
API Number of districts Change in percentagea Total population (%) Change in percentagea
2013 % 2016 % 2013 % 2016 %
< 1.0 60 7.2 92 10.9 3.7 7 887 232 9.2 11 730 861 12.7 3.4
1.0–5.0 128 15.3 224 26.5 11.2 14 941 965 17.5 27 787 000 30.0 12.5
5.1–100 527 63.2 475 56.2 (7.0) 54 487 279 63.8 50 005 687 54.0 (9.8)
> 100 119 14.3 54 6.4 (7.9) 8 133 374 9.5 3 093 995 3.3 (6.2)
Total 834 845 85 449 850 92 617 543
aDifference in percentages from 2013 to 2016, numbers in brackets indicating negative
A B C
Fig. 5 Malaria transmission intensity maps by districts in a: 2013, b): 2016, and c): Difference in API between 2013 and 2016 (positive indicating
decrease and negative indicating increase). API: annual parasite incidence per 1000 population
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